RecruitingPhase 2NCT06952699
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Studying Narcolepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Takeda
- Principal Investigator
- Study DirectorTakeda
- Intervention
- TAK-360(drug)
- Enrollment
- 88 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2025 – 2026
Study locations (30)
- Takeda Site 14, Redwood City, California, United States
- Takeda Site 10, Santa Ana, California, United States
- Takeda Site 1, Colorado Springs, Colorado, United States
- Takeda Site 13, Brandon, Florida, United States
- Takeda Site 3, Orlando, Florida, United States
- Takeda Site 4, St Louis, Missouri, United States
- Takeda Site 8, Denver, North Carolina, United States
- Takeda Site 6, Huntersville, North Carolina, United States
- Takeda Site 5, Cincinnati, Ohio, United States
- Takeda Site 2, Columbia, South Carolina, United States
- Takeda Site 7, San Antonio, Texas, United States
- Takeda Site 11, Norfolk, Virginia, United States
- Takeda Site 28, Beijing, Beijing Municipality, China
- Takeda Site 29, Guangzhou, Guangzhou, China
- Takeda Site 27, Shanghai, Shanghai Municipality, China
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06952699 on ClinicalTrials.govOther trials for Narcolepsy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07365566Pain Assessment in Patients With Idiopathic REM Sleep Behaviour DisorderUniversity Hospital, Toulouse
- RECRUITINGPHASE3NCT07363720A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyTakeda
- RECRUITINGNCT07299097Epidemiology of Narcolepsy Type 1 and Type 2 in SpainTakeda
- RECRUITINGPHASE2NCT06809803Extended-release Sodium Oxybate in ChildrenStanford University
- RECRUITINGPHASE1NCT06961266A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1Jazz Pharmaceuticals
- RECRUITINGNCT06292598Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control PopulationCentre Hospitalier Universitaire de Nīmes
- RECRUITINGNANCT06797284The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake DisordersSecond Affiliated Hospital of Soochow University
- RECRUITINGNCT06586138Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness TestHospices Civils de Lyon